Presentation is loading. Please wait.

Presentation is loading. Please wait.

Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of.

Similar presentations


Presentation on theme: "Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of."— Presentation transcript:

1 Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of life  Pythia T Nieuwkerk, Petra J Hajenius, M.D., Willem M Ankum, M.D., Ph.D., Fulco Van der Veen, M.D., Ph.D., Wouter Wijker, Ph.D., Patrick M.M Bossuyt, Ph.D.  Fertility and Sterility  Volume 70, Issue 3, Pages (September 1998) DOI: /S (98)00212-X

2 FIGURE 1 Physical functioning (A), role functioning (B), social functioning (C), and pain (D) in patients who received systemic methotrexate therapy versus laparoscopic salpingostomy (means ± SEs). • = systemic methotrexate; ♢ = laparoscopic salpingostomy. Fertility and Sterility  , DOI: ( /S (98)00212-X)


Download ppt "Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of."

Similar presentations


Ads by Google